Effects of nintedanib in idiopathic pulmonary fibrosis - analysis on long term prognosis and predictive factors
Not Applicable
Recruiting
- Conditions
- Idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000021036
- Lead Sponsor
- ational Hospital Organization Tokyo Medical Center, Department of Respiratory Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Cases with severe liver, renal or metabolic dysfunction. 2. Complicated by malignancy. 3. Any other cases that the attending physician considers to be inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival, cumulative incidence of acute exacerbation
- Secondary Outcome Measures
Name Time Method Overall survival in individual pre-assumed predictive factors, cumulative incidence of acute exacerbation in individual pre-assumed predictive factors, adverse effects